Specifically, GDF-15 seems to limit tumor growth in early tumor stages, whereas cancer cells may exploit GDF-15 to escape immune surveillance in later stages, promoting a protumorigenic environment which supports tumor proliferation and metastatic spread (15–17). This evidence concerns the gene GDF15 and cancer.